Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000493011 | SCV000582618 | likely pathogenic | not provided | 2015-11-16 | criteria provided, single submitter | clinical testing | The L908H variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The L908H variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position within the ligand-binding region that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. The AR gene has a low rate of benign missense variation and missense variants are a common mechanism of disease. Missense variants in nearby residues (V904L/M, P905S/R/H, G910R, V912L) have been reported in the Human Gene Mutation Database in association with androgen insensitivity syndrome (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded |